Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma ; volume:41 ; number:1 ; day:17 ; month:11 ; year:2022 ; pages:1-19 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (17.11.2022), 1-19, 12.2022
- Urheber
-
Lucarini, Valeria
Melaiu, Ombretta
D’Amico, Silvia
Pastorino, Fabio
Tempora, Patrizia
Scarsella, Marco
Pezzullo, Marco
Ninno, Adele De
D’Oria, Valentina
Cilli, Michele
Emionite, Laura
Infante, Paola
Marcotullio, Lucia Di
Ioris, Maria Antonietta De
Barillari, Giovanni
Alaggio, Rita
Businaro, Luca
Ponzoni, Mirco
Locatelli, Franco
Fruci, Doriana
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02525-9
- URN
-
urn:nbn:de:101:1-2023013021042297212025
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lucarini, Valeria
- Melaiu, Ombretta
- D’Amico, Silvia
- Pastorino, Fabio
- Tempora, Patrizia
- Scarsella, Marco
- Pezzullo, Marco
- Ninno, Adele De
- D’Oria, Valentina
- Cilli, Michele
- Emionite, Laura
- Infante, Paola
- Marcotullio, Lucia Di
- Ioris, Maria Antonietta De
- Barillari, Giovanni
- Alaggio, Rita
- Businaro, Luca
- Ponzoni, Mirco
- Locatelli, Franco
- Fruci, Doriana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
TH9 cells in anti-tumor immunity
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Impairment of NKG2D-mediated tumor immunity by TGF-β
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Targeting tumor cells with antibodies enhances anti-tumor immunity
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
TH9 cells in anti-tumor immunity
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Impairment of NKG2D-mediated tumor immunity by TGF-β
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Targeting tumor cells with antibodies enhances anti-tumor immunity
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
TH9 cells in anti-tumor immunity
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Impairment of NKG2D-mediated tumor immunity by TGF-β
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors